- Home
- ATLCP vs ICUCW Comparison
ATLCP vs ICUCW Comparison
Compare ATLCP & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLCP
- ICUCW
- Stock Information
- Founded
- ATLCP N/A
- ICUCW N/A
- Country
- ATLCP United States
- ICUCW United States
- Employees
- ATLCP 417
- ICUCW 19
- Industry
- ATLCP Finance: Consumer Services
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- ATLCP Finance
- ICUCW Health Care
- Exchange
- ATLCP Nasdaq
- ICUCW Nasdaq
- Market Cap
- ATLCP N/A
- ICUCW N/A
- IPO Year
- ATLCP N/A
- ICUCW 2021
- Fundamental
- Price
- ATLCP $21.95
- ICUCW $0.03
- Analyst Decision
- ATLCP
- ICUCW
- Analyst Count
- ATLCP 0
- ICUCW 0
- Target Price
- ATLCP N/A
- ICUCW N/A
- AVG Volume (30 Days)
- ATLCP N/A
- ICUCW N/A
- Earning Date
- ATLCP N/A
- ICUCW N/A
- Dividend Yield
- ATLCP N/A
- ICUCW N/A
- EPS Growth
- ATLCP N/A
- ICUCW N/A
- EPS
- ATLCP N/A
- ICUCW N/A
- Revenue
- ATLCP N/A
- ICUCW N/A
- Revenue This Year
- ATLCP N/A
- ICUCW N/A
- Revenue Next Year
- ATLCP N/A
- ICUCW N/A
- P/E Ratio
- ATLCP N/A
- ICUCW N/A
- Revenue Growth
- ATLCP N/A
- ICUCW N/A
- 52 Week Low
- ATLCP N/A
- ICUCW N/A
- 52 Week High
- ATLCP N/A
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- ATLCP 29.73
- ICUCW N/A
- Support Level
- ATLCP $21.97
- ICUCW N/A
- Resistance Level
- ATLCP $22.25
- ICUCW N/A
- Average True Range (ATR)
- ATLCP 0.12
- ICUCW 0.00
- MACD
- ATLCP 0.02
- ICUCW 0.00
- Stochastic Oscillator
- ATLCP 0.10
- ICUCW 0.00
About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.